The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Percutaneous Cardiac Recirculation-Mediated Gene Transfer of an Inhibitory Phospholamban Peptide Reverses Advanced Heart Failure in Large Animals
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This potential therapeutic strategy was initially tested in large animals using pseudo-phosphorylated PLN constructs [93], and it is now being reconsidered in the light of the discovery of the first SERCA-activating regulin, DWORF [14, 77, 94–96].”
From Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition (2024) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
del Monte, F., Williams, E., Lebeche, D., Schmidt, U., Rosenzweig, A., Gwathmey, J. K., Lewandowski, E. D., & Hajjar, R. J. (2001) · Circulation · doi:10.1161/hc3601.095574 · Cited by 382
Self-citationKaspar, B. K., Roth, D. M., Chin Lai, N., Drumm, J. D., Erickson, D. A., McKirnan, M. D., & Hammond, H. K. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.665 · Cited by 59
Research works printed but not linked: 43
- Bukhari, 2005, Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications, Expert Rev Cardiovasc Ther, 3, 85, 10.1586/14779072.3.1.85 · DOI
- Sesti, 2004, Gene therapy in congestive heart failure, Circulation, 110, 242, 10.1161/01.CIR.0000137593.62669.67 · doi:10.1161/01.cir.0000137593.62669.67
- Hoshijima, 2005, Gene therapy targeted at calcium handling as an approach to the treatment of heart failure, Pharmacol Ther, 105, 211, 10.1016/j.pharmthera.2004.10.006 · DOI
- MacLennan, 2003, Phospholamban: a crucial regulator of cardiac contractility, Nat Rev Mol Cell Biol, 4, 566, 10.1038/nrm1151 · DOI · Paper page
- Hasenfuss, 2002, Calcium cycling in congestive heart failure, J Mol Cell Cardiol, 34, 951, 10.1006/jmcc.2002.2037 · DOI · Paper page
- Minamisawa, 1999, Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy, Cell, 99, 313, 10.1016/S0092-8674(00)81662-1 · DOI · Paper page
- Chien, 2000, Genomic circuits and the integrative biology of cardiac diseases, Nature, 407, 227, 10.1038/35025196 · DOI · Paper page
- Chien, 2003, Calcium and heart failure: the cycle game, Nat Med, 9, 508, 10.1038/nm0503-508 · DOI
- Hoshijima, 2002, Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery, Nat Med, 8, 864, 10.1038/nm739 · DOI · Paper page
- Iwanaga, 2004, Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats, J Clin Invest, 113, 727, 10.1172/JCI18716 · DOI · Paper page
- Williams, 2004, Viral-based myocardial gene therapy approaches to alter cardiac function, Annu Rev Physiol, 66, 49, 10.1146/annurev.physiol.66.032102.141555 · DOI
- Thompson, 2004, Gene therapy for heart failure, Ann Med, 36, 106, 10.1080/17431380410032652 · DOI
- De Grand, 2003, An operational near-infrared fluorescence imaging system prototype for large animal surgery, Tech Cancer Res Treat, 2, 553, 10.1177/153303460300200607 · DOI · Paper page
- Kaye, 2003, Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation, Circulation, 108, 1795, 10.1161/01.CIR.0000096051.23734.28 · DOI
- Chu, 1988, Isolation of sarcoplasmic reticulum fractions referable to longitudinal tubules and junctional terminal cisternae from rabbit skeletal muscle, Methods Enzymol, 157, 36, 10.1016/0076-6879(88)57066-0 · DOI
- Fabiato, 1988, Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands, Methods Enzymol, 157, 378, 10.1016/0076-6879(88)57093-3 · DOI · Paper page
- Patton, 2004, Some precautions in using chelators to buffer metals in biological solutions, Cell Calcium, 35, 427, 10.1016/j.ceca.2003.10.006 · DOI · Paper page
- Seidler, 1989, Cyclopiazonic acid is a specific inhibitor of the Ca2+-ATPase of sarcoplasmic reticulum, J Biol Chem, 264, 17816, 10.1016/S0021-9258(19)84646-X · DOI · Paper page
- Weiss, 1997, In situ histochemical detection of beta-galactosidase activity in lung: assessment of X-gal reagent in distinguishing LacZ gene expression and endogenous beta-galactosidase activity, Hum Gene Ther, 8, 1545, 10.1089/hum.1997.8.13-1545 · DOI
- Zsengeller, 2000, Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection, J Virol, 74, 9655, 10.1128/JVI.74.20.9655-9667.2000 · DOI
- Tomaselli, 1999, Electrophysiological remodeling in hypertrophy and heart failure, Cardiovasc Res, 42, 270, 10.1016/S0008-6363(99)00017-6 · DOI · Paper page
- Schwinger, 1997, Effect of cyclopiazonic acid on the force-frequency relationship in human nonfailing myocardium, J Pharmacol Exp Ther, 283, 286, 10.1016/S0022-3565(24)36993-9 · DOI
- Miyamoto, 2000, Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure, Proc Natl Acad Sci U S A, 97, 793, 10.1073/pnas.97.2.793 · DOI · Paper page
- Luo, 1996, Phospholamban gene dosage effects in the mammalian heart, Circ Res, 78, 839, 10.1161/01.RES.78.5.839 · DOI
- Nef, 2006, Reduced sarcoplasmic reticulum Ca2+-ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium, Mol Cell Biochem, 282, 53, 10.1007/s11010-006-1171-7 · DOI
- Schwinger, 1999, Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation, J Mol Cell Cardiol, 31, 479, 10.1006/jmcc.1998.0897 · DOI · Paper page
- Prestle, 1999, Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart, Cardiovasc Res, 43, 323, 10.1016/S0008-6363(99)00119-4 · DOI
- He, 1999, Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility, Circulation, 100, 974, 10.1161/01.CIR.100.9.974 · DOI
- Eizema, 2000, Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1–responsive cardiac promoter, Circulation, 101, 2193, 10.1161/01.CIR.101.18.2193 · DOI
- Dieterle, 2005, Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure, Cardiovasc Res, 67, 678, 10.1016/j.cardiores.2005.04.029 · DOI
- Song, 2003, Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy, J Clin Invest, 111, 859, 10.1172/JCI200316738 · DOI
- Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J Clin Invest, 111, 869, 10.1172/JCI17892 · DOI · Paper page
- Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
- Weitzman, 2005, Breaking the barriers to global gene delivery, Nat Biotechnol, 23, 305, 10.1038/nbt0305-305 · DOI
- Leiden, 2000, Human gene therapy: the good, the bad, and the ugly, Circ Res, 86, 923, 10.1161/01.RES.86.9.923 · doi:10.1161/01.res.86.9.923
- Davidson, 2001, Cardiac gene delivery with cardiopulmonary bypass, Circulation, 104, 131, 10.1161/01.CIR.104.2.131 · doi:10.1161/01.cir.104.2.131
- Roth, 2004, Nitroprusside increases gene transfer associated with intracoronary delivery of adenovirus, Hum Gene Ther, 15, 989, 10.1089/hum.2004.15.989 · DOI
- Raake, 2004, Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery, J Am Coll Cardiol, 44, 1124, 10.1016/j.jacc.2004.05.074 · DOI
- del Monte, 2004, Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling, Proc Natl Acad Sci U S A, 101, 5622, 10.1073/pnas.0305778101 · DOI · Paper page
- Zhu, 2005, Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer, Circulation, 112, 2650, 10.1161/CIRCULATIONAHA.105.565598 · DOI
- Kawamoto, 2005, Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a beta-actin hybrid promoter, Mol Ther, 11, 980, 10.1016/j.ymthe.2005.02.009 · DOI
- Wang, 2005, AAV-mediated gene transfer for treatment of hemophilia, Curr Gene Ther, 5, 349, 10.2174/1566523054065048 · DOI
- Bessis, 2004, Immune responses to gene therapy vectors: influence on vector function and effector mechanisms, Gene Ther, 11, S10, 10.1038/sj.gt.3302364 · DOI · Paper page
Cited by
The war against heart failure: the Lancet lecture
Braunwald, E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61889-4 · Cited by 811
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
Animal Models of Heart Failure: A Scientific Statement From the American Heart Association
Houser, S. R., Margulies, K. B., Murphy, A. M., Spinale, F. G., Francis, G. S., Prabhu, S. D., Rockman, H. A., Kass, D. A., Molkentin, J. D., Sussman, M. A., et al. (2012) · Circulation Research · doi:10.1161/res.0b013e3182582523 · Cited by 435
Dixon, J. A., & Spinale, F. G. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.814459 · Cited by 294
Heart Failure With Normal Left Ventricular Ejection Fraction
Maeder, M. T., & Kaye, D. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.007 · Cited by 270
Self-citation
Metadata
- Authors
- Kaye, D. M., Preovolos, A., Marshall, T., Byrne, M., Hoshijima, M., Hajjar, R., Mariani, J. A., Pepe, S., Chien, K. R., & Power, J. M.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 50
- Issue
- 3
- Pages
- 253-260
- ISSN
- 0735-1097
- Cited by
- 125
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2244 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.